Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBL-514 for Reducing Abdominal Subcutaneous Fat
NCT04698642Phase 2Completed
- Sponsor
- Caliway Biopharmaceuticals
- Start
- Feb 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CBL-514, sponsored by Caliway Biopharmaceuticals. Started Feb 2020; status: completed.
02
Drugs
CBL-514
Beyond the preview
Go deeper on NCT04698642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04698642.